FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Country

Document

No Title 0.42 MB
Registration Date 3 Sep 2022
Revision Date 3 Sep 2022
Share

Exparel

(0)

Medicine Pharmaceuticals

Analgesic

Drug Information

Generic
Bupivacaine Liposome
Drug Class
Non-Opioid
Therapeutic Class
Analgesic
Dosage form
Suspension
Therapeutic Area
1.Post-Surgical Pain Relief

Nanomaterials

Manufacturer Asserted

Liposome

Nanoliposome

Indication

EXPAREL® (bupivacaine liposome injectable suspension) is indicated for single-dose infiltration in patients aged 6 years and older to produce postsurgical local analgesia and in adults as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia. Safety and efficacy have not been established in other nerve blocks.

Benefit

EXPAREL® (bupivacaine liposome injectable suspension) is a local analgesic administered at the time of surgery to control pain and reduce or eliminate the use of opioids for acute postsurgical pain.